Sartorius AG (XTER:SRT3) Other Long Term Assets : €200 Mil (As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG Other Long Term Assets?

Sartorius AG's other long-term assets for the quarter that ended in Mar. 2024 was €200 Mil.

Sartorius AG's quarterly other long-term assets increased from Sep. 2023 (€199 Mil) to Dec. 2023 (€202 Mil) but then stayed the same from Dec. 2023 (€202 Mil) to Mar. 2024 (€200 Mil).

Sartorius AG's annual other long-term assets increased from Dec. 2021 (€137 Mil) to Dec. 2022 (€238 Mil) but then declined from Dec. 2022 (€238 Mil) to Dec. 2023 (€202 Mil).

Sartorius AG Other Long Term Assets Historical Data

The historical data trend for Sartorius AG's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Other Long Term Assets Chart

Sartorius AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

57.26

80.67

137.40

237.50

202.40

Sartorius AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															206.10	189.50	198.50	202.40	200.10

Sartorius AG Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Sartorius AG (XTER:SRT3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT3) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

SOAGY:USA SSSGY:USA SUVPF:USA SARTF:USA 1SRT3:Italy SRT3d:UK 0NIR:UK SRT3:Austria

Address

Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079

Website

https://www.sartorius.com

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Executives

Dr. Joachim Kreuzburg

Board of Directors

Sartorius AG (XTER:SRT3) Headlines

No Headlines